Is PSG.DE stock a buy right now?

Meyka AI currently grades PSG.DE **B+ (75.01)** with a BUY suggestion, but the 1-year forecast at **€27.36** implies short-term downside. For an oversold bounce trade, use tight risk controls and wait for volume-confirmed reversal before adding size.

What are realistic price targets for PSG.DE stock?

Meyka-aligned targets: conservative **€27.00**, base **€30.50**, bullish **€33.00**. These match model forecasts and medium-term growth assumptions; adjust targets to your time horizon and risk tolerance.

Which levels should traders watch for a PSG.DE stock bounce?

Watch support at the 50-day average **€28.52** and 200-day average **€26.10**. A confirmed breakout above **€30.00** validates a larger bounce; use a stop near **€27.80** on tactical entries.

How reliable is Meyka AI's PSG.DE stock forecast?

Meyka AI's forecasts are model-based and combine fundamental and sector inputs. The projections are informative but not guarantees. Use them with your own due diligence and risk management.

DE Stocks

PSG.DE PharmaSGP pre-market 22 Jan 2026: Oversold bounce setup after intraday dip, watch €30 resistance

ByDanny Kontos January 22, 2026

PSG.DE stock opens pre-market on XETRA at €29.00 after an intraday low of €28.60, creating a short-term pullback traders may treat as an oversold bounce opportunity. PharmaSGP Holding SE (PSG.DE) trades in Germany’s Healthcare sector with market cap €333,862,500.00 and EPS €1.68. With average volume running at 5,399 shares and today’s volume already 12,424, watch for a quick mean reversion toward the €30.00 yearly resistance if momentum confirms.